未找到相关数据
Outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma and histology variants: Analysis of the UNITE study.
被引：2
作者：
Jindy, Tanya
Jiang, Cindy Y.
Alhalabi, Omar
Nguyen, Charles B.
Nizam, Amanda
Basu, Arnab
Bilen, Mehmet Asim
Zakharia, Yousef
Milowsky, Matthew I.
Brown, Jason R.
Kilari, Deepak
Emamekhoo, Hamid
Hoimes, Christopher J.
Khaki, Ali Raza
Gupta, Shilpa
Grivas, Petros
Bellmunt, Joaquim
Campbell, Matthew T.
Alva, Ajjai Shivaram
Koshkin, Vadim S.
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Hematol Oncol Fellowship, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[4] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[5] Cleveland Clin, Cleveland, OH USA
[6] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[8] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[10] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[11] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI USA
[12] Univ Wisconsin, Madison, WI USA
[13] Duke Univ, Duke Canc Inst, Durham, NC USA
[14] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA USA
[15] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[16] Univ Washington, Div Hematol & Oncol, Seattle, WA USA
[17] Fred Hutchinson Canc Ctr, Seattle, WA USA
[18] Dana Farber Canc Inst, Boston, MA USA
[19] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[20] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI USA
[21] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA USA
关键词：
283-183-138-12099;
261-492-3532-2370-7650-2700;
261-566-9263;
4;
2;
3224;
3;
1;
D O I：
10.1200/JCO.2024.42.4_suppl.652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：652 / 652
页数：1
相关论文